We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $61.5B
1-Year Est. Return 30.7%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$31.1B
AUM Growth
-$798M
Cap. Flow
-$76.3M
Cap. Flow %
-0.25%
Top 10 Hldgs %
19.76%
Holding
2,147
New
190
Increased
722
Reduced
893
Closed
174

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$298M
2
KMI icon
Kinder Morgan
KMI
+$158M
3
KO icon
Coca-Cola
KO
+$138M
4
PM icon
Philip Morris
PM
+$95.2M
5
BABA icon
Alibaba
BABA
+$94.8M

Sector Composition

Rank Sector Weight
1 Healthcare 15.6%
2 Consumer Staples 13.42%
3 Energy 10.54%
4 Financials 8.95%
5 Utilities 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
D icon
26
Dominion Energy
D
$62.2B
$230M 0.74%
3,335,896
-190,236
-5% -$13.1M
GSK icon
27
GSK
GSK
$107B
$227M 0.73%
3,944,693
+556,345
+16% +$34.1M
WFC icon
28
Wells Fargo
WFC
$257B
$202M 0.65%
3,900,102
-948,184
-20% -$48.8M
SLXP
29
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$189M 0.61%
1,206,557
-7,337
-0.6% -$1.06M
RDS.B
30
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$188M 0.6%
2,373,329
-235,231
-9% -$19.8M
HAL icon
31
Halliburton
HAL
$26.2B
$186M 0.6%
2,883,727
+31,879
+1% +$2.19M
BP icon
32
BP
BP
$112B
$184M 0.59%
5,120,880
-751,750
-13% -$29.8M
JPM icon
33
JPMorgan Chase
JPM
$928B
$182M 0.58%
3,016,321
+20,850
+0.7% +$1.22M
ILMN icon
34
Illumina
ILMN
$29.2B
$181M 0.58%
1,134,959
-104,381
-8% -$17.4M
DXCM icon
35
DexCom
DXCM
$29.2B
$178M 0.57%
17,787,732
-15,660
-0.1% -$160K
AEP icon
36
American Electric Power
AEP
$71.7B
$173M 0.56%
3,306,941
-107,838
-3% -$5.7M
KMI icon
37
Kinder Morgan
KMI
$71.1B
$167M 0.54%
4,353,092
+4,164,621
+2,210% +$158M
PFE icon
38
Pfizer
PFE
$144B
$166M 0.53%
5,905,395
+313,435
+6% +$8.8M
PEP icon
39
PepsiCo
PEP
$198B
$156M 0.5%
1,674,957
-70,980
-4% -$6.48M
BIIB icon
40
Biogen
BIIB
$31.9B
$150M 0.48%
453,580
+33,801
+8% +$11.1M
GILD icon
41
Gilead Sciences
GILD
$166B
$148M 0.48%
1,390,007
-83,725
-6% -$8.2M
ALKS icon
42
Alkermes
ALKS
$8.12B
$141M 0.45%
3,295,378
-203,898
-6% -$9.14M
DYAX
43
DELISTED
DYAX CORPORATION
DYAX
$137M 0.44%
13,584,600
CBST
44
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$136M 0.44%
2,051,064
-49,270
-2% -$3.24M
BMY icon
45
Bristol-Myers Squibb
BMY
$130B
$130M 0.42%
2,545,692
-117,108
-4% -$5.85M
NXPI icon
46
NXP Semiconductors
NXPI
$61.1B
$130M 0.42%
1,903,400
-1,300
-0.1% -$86.5K
SLCA
47
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$128M 0.41%
2,052,447
-338,289
-14% -$21.1M
MLM icon
48
Martin Marietta Materials
MLM
$34.4B
$123M 0.4%
951,860
+262,571
+38% +$33.8M
BLK icon
49
Blackrock
BLK
$170B
$118M 0.38%
358,244
+11,984
+3% +$3.86M
CVS icon
50
CVS Health
CVS
$138B
$117M 0.38%
1,475,792
-39,542
-3% -$3.12M

Similar funds

Federated Hermes's Q3 2014 Portfolio in Review

As of Q3 2014, Federated Hermes held 2,147 positions worth $31.1B, down 2.5% from $31.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Federated Hermes's Q3 2014 filing shows 190 new, 722 increased, 893 reduced and 174 closed positions. Its largest new stake was Alibaba: 1,055,100 shares worth $93.7M. The largest sale was LORILLARD INC COM STK, an estimated $452M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Consumer Staples and Energy.

  • Federated Hermes's largest Q3 2014 buy was Alibaba: 1,055,100 shares worth $93.7M.
  • Federated Hermes added most to Procter & Gamble in Q3 2014, an estimated $298M increase.
  • Federated Hermes's biggest Q3 2014 reduction was LORILLARD INC COM STK, cutting an estimated $452M.
  • Federated Hermes fully exited INTERMUNE INC in Q3 2014, selling an estimated $57M.
  • Federated Hermes's ten largest holdings make up 20% of its $31.1B portfolio in Q3 2014.
  • Federated Hermes opened 190 new positions and closed 174 in Q3 2014.
  • Federated Hermes's portfolio value fell 2.5% quarter-over-quarter to $31.1B.

Based on Federated Hermes's 13F filing for Q3 2014, filed 12 Nov 2014.